Skip to content
Disclosery

Healthcare Value Capital, LLC

Follow

13F filer, CIK 1458461, Woodcliff Lake, NJ

Healthcare Value Capital, LLC reported $50,184,000 across 23 holdings for the quarter ended 2021-06-30, in a 13F-HR filed 2021-08-16. Its ten largest share positions make up 73.72% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-21-005307

Period
2021-06-30
Reported value
$50.2M
Holdings
23
Top 10 weight
73.72%
New
3
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BMYadded+25,000$1.67M
MDXGnew+125,000$1.56M
MRKadded+20,000$1.56M
AZNadded+25,000$1.5M
ALKSadded+50,000$1.23M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AUPHexited-100,000-$1.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2021

Share positions as resolved from 13F-HR 0000919574-21-005307, largest first. % of portfolio is the value over $46,240,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: 70,000 shares; 2020Q1: 50,000 shares; 2020Q2: 50,000 shares; 2020Q3: 50,000 shares; 2020Q4: 50,000 shares; 2021Q1: 75,000 shares; 2021Q2: 75,000 shares 75,000$5.17M11.17%0Timeline
GLAXOSMITHKLINE PLC-ADRGLAXOSMITHKLINE PLC-ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: 100,000 shares; 2020Q1: 100,000 shares; 2020Q2: 100,000 shares; 2020Q3: 100,000 shares; 2020Q4: 100,000 shares; 2021Q1: 100,000 shares; 2021Q2: 100,000 shares 100,000$3.98M8.61%0
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 100,000 shares; 2021Q2: 100,000 shares 100,000$3.92M8.47%0Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 100,000 shares; 2021Q2: 150,000 shares 150,000$3.68M7.95%+50,000Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 25,000 shares; 2021Q2: 50,000 shares 50,000$3.34M7.23%+25,000Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 20,000 shares; 2021Q2: 40,000 shares 40,000$3.11M6.73%+20,000Timeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: 75,000 shares; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 25,000 shares; 2021Q2: 50,000 shares 50,000$3M6.48%+25,000Timeline
CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: 150,000 shares; 2020Q1: 250,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares; 2020Q4: 250,000 shares; 2021Q1: 450,000 shares; 2021Q2: 500,000 shares 500,000$2.9M6.27%+50,000
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 200,000 shares; 2021Q2: 200,000 shares 200,000$2.57M5.57%0Timeline
AMRYT PHARMA LTD - SPNR ADRAMRYT PHARMA LTD - SPNR ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 155,555 shares; 2021Q2: 200,000 shares 200,000$2.43M5.25%+44,445
COLLCOLLEGIUM PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 100,000 shares; 2021Q2: 100,000 shares 100,000$2.36M5.11%0Timeline
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: 300,000 shares; 2020Q1: 500,000 shares; 2020Q2: 500,000 shares; 2020Q3: 500,000 shares; 2020Q4: 500,000 shares; 2021Q1: 500,000 shares; 2021Q2: 500,000 shares 500,000$2.18M4.71%0
TYME TECHNOLOGIES INC COMTYME TECHNOLOGIES INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: 2,175,000 shares; 2020Q1: 2,175,000 shares; 2020Q2: 2,175,000 shares; 2020Q3: 2,175,000 shares; 2020Q4: 2,175,000 shares; 2021Q1: 1,500,000 shares; 2021Q2: 1,500,000 shares 1,500,000$1.89M4.09%0
VYNE THERAP.VYNE THERAP.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 400,000 shares; 2021Q2: 450,000 shares 450,000$1.58M3.42%+50,000
GREENLANE HLDGS INCGREENLANE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: 175,000 shares; 2020Q1: 225,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares; 2020Q4: 250,000 shares; 2021Q1: 250,000 shares; 2021Q2: 350,000 shares 350,000$1.56M3.38%+100,000
MDXGMIMEDX GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: not reported; 2021Q2: 125,000 shares 125,000$1.56M3.38%newTimeline
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: 100,000 shares; 2020Q4: 100,000 shares; 2021Q1: 100,000 shares; 2021Q2: 100,000 shares 100,000$528K1.14%0
GAMIDA CELL LTDGAMIDA CELL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: 50,000 shares; 2021Q1: 50,000 shares; 2021Q2: 75,000 shares 75,000$481K1.04%+25,000

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
PROSHARES TRPROSHARES TR ULTRAPRO SHT QQQcall100,000$914Knew
ProShares UltraPro Short S&…ProShares UltraPro Short S&P 500 COMcall50,000$911K-50,000
AMARIN CORP PLCAMARIN CORP PLC SPONS ADR NEWcall200,000$876K-100,000
IRWDIRONWOOD PHARMACEUTICALS INC COMMON STOCKcall50,000$644K0
PROSHARES TR IIPROSHARES TR II FUNDcall25,000$602Knew

Sold out in Q2 2021

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AUPHAURINIA PHARMACEUTICALS INC100,000$1.3Mshares
Proshares VIX Short-TermProshares VIX Short-Term100,000$935Kcall

How Q2 2021 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-21-005307 base2021-08-16acceptance time not in the bulk data set